SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912057-01-538776
Filing Date
2001-11-13
Accepted
2001-11-13 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 13D a2063259zsc13d.htm SC 13D 58724
3 EXHIBIT 99.A a2063259zex-99_a.htm EX-99.A 9801
4 EXHIBIT 99.B a2063259zex-99_b.htm EX-99.B 21133
  Complete submission text file 0000912057-01-538776.txt   92081
Mailing Address 128 SPRING STREET LEXINGTON MA 02173
Business Address 1199 MADIA STREET PASADENA CA 91103 6267921235
AUTOIMMUNE INC (Subject) CIK: 0000879106 (see all company filings)

IRS No.: 133489062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44757 | Film No.: 1781474
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice